"10.1371_journal.pone.0099781","plos one","2014-06-30T00:00:00Z","Lucile Mercadel; Marie Metzger; Jean Philippe Haymann; Eric Thervet; Jean-Jacques Boffa; Martin Flamant; François Vrtovsnik; Pascal Houillier; Marc Froissart; Bénédicte Stengel; the NephroTest Study Group","Inserm, Centre for research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity, and Kidney Diseases Team, Villejuif, France; Department of Nephrology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Sud 11, U1018, Villejuif, France; Department of Physiology and Nephrology, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Inserm U702, Paris, France; Department of Nephrology, Hôpital Européen G Pompidou, Assistance Publique-hôpitaux de Paris, Paris, France; Department of Nephrology, Hôpital Tenon, Assistance Publique-hôpitaux de Paris, université Pierre et Marie Curie, Paris, France; Department of Physiology, Hôpital Bichat, Assistance Publique-hôpitaux de Paris, Paris, France; Inserm U699, Paris, France; Department of Nephrology, Hôpital Bichat, Assistance Publique-hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France; Department of Physiology, Hôpital Européen G Pompidou, Assistance Publique-hôpitaux de Paris, Université Paris Descartes, Paris, France","Conceived and designed the experiments: M. Froissart BS LM MM. Analyzed the data: MM LM. Wrote the paper: LM MM BS. Carried out the laboratory reference measurements: M. Flamant JPH PH M. Froissart. Managed the biobank: M. Froissart BS. Managed the data collection: MM BS M. Froissart. Discussed analyses, interpretation and presentation: ET JJB M. Flamant FV PH.","This study was partly funded by La Roche Ltd. M. Froissart has received consulting or lecture fees or research funds from Affymax, Genzyme, Hoffmann-La Roche, Novartis, Sandoz, Shire, Takeda, and Vifor International. M. Froissart has been employed by Amgen since January 1, 2011, but was a full-time academic associate professor during the time of study conception and data collection. B.S. has received research funds from Amgen, Baxter, Genzyme (Sanofi), Fresenius, MSD, and GSK. Dr Barbara Sasu and Vimal Patel provided advised and performed hepcidin measurements at Amgen laboratories (Amgen Inc., Thousand Oaks, CA). In order to enable hepcidin measurements, this study was labelled as an Investigator Sponsored Study (BS) by Amgen. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","06","Lucile Mercadel","LM",11,TRUE,1,NA,2,3,TRUE,TRUE,TRUE,4,"3;7;8;11",TRUE
